Coverage
Filings
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 2 Feb 2021 |
| Novozymes completes acquisition of Microbiome Labs | 8 Jan 2021 |
| Novozymes acquires Microbiome Labs | 18 Dec 2020 |
| New sales reporting structure introduced. 2020 organic sales growth outlook now expected at 0%, from previously -2% to +2% | 11 Dec 2020 |
| Proposal of candidates to the Board of Directors | 9 Dec 2020 |